Why is Biogen, Inc. ?
- INTEREST(Q) Highest at USD 72.6 MM
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 14.65%, its profits have risen by 22.6% ; the PEG ratio of the company is 0.6
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you hold?
- Overall Portfolio exposure to Biogen, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Biogen, Inc. for you?
Medium Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 2,116.7 MM
Highest at 1,433.33
Fallen by 1.81% (YoY
Highest at USD 2,561.5 MM
Highest at USD 1,040.6 MM
Highest at 40.62 %
Highest at USD 779.7 MM
Highest at USD 665.26 MM
Highest at USD 4.33
Highest at USD 72.6 MM
Here's what is working for Biogen, Inc.
Operating Cash Flows (USD MM)
Operating Profit to Interest
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Raw Material Cost as a percentage of Sales
Here's what is not working for Biogen, Inc.
Interest Paid (USD MM)
Interest Paid (USD MM)






